Evidence map›Paper›PMID 36697459›Full record

ArticleScientific reports2023

Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.

Yiyan Zhai, Xinkui Liu, Zhihong Huang, Jingyuan Zhang, Antony Stalin, Yingying Tan, Fanqin Zhang, Meilin Chen, Rui Shi, Jiaqi Huang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Characterization of SUSD3 as a novel prognostic biomarker and therapeutic target for breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Frontiers in oncology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Regulatory mechanisms of dopamine metabolism in a marineSynthetic and systems biotechnology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Yiyan ZhaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Xinkui LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhihong HuangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Jingyuan ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Antony StalinInstitute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 611731, China.
Yingying TanSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Fanqin ZhangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Meilin ChenSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Rui ShiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Jiaqi HuangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Chao WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Zhishan WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Shan LuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.
Leiming YouSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China. youleiming@bucm.edu.cn.
Jiarui WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China. exogamy@163.com.
Beijing University of Chinese Medicine · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stomach adenocarcinoma (STAD) is a type of cancer which often at itsadvanced stage apon diagnosis and mortality in clinical practice. Several factors influencethe prognosis of STAD, including the expression and regulation of immune cells in the tumor microenvironment. We here investigated the biomarkers related to the diagnosis and prognosis of gastric cancer, hoping to provide insights for the diagnosis and treatment of gastric cancer in the future. STAD and normal patient RNA sequencing data sets were accessed from the cancer genome atlas (TCGA database). Differential genes were determined and obtained by using the R package DESeq2. The stromal, immune, and ESTIMATE scores are calculated by the ESTIMATE algorithm, followed by the modular genes screening using the R package WGCNA. Subsequently, the intersection between the modular gene and the differential gene was taken and the STRING database was used for PPI network module analysis. The R packages clusterProfiler, enrichplot, and ggplot2 were used for GO and KEGG enrichment analysis. Cox regression analysis was used to screen survival-related genes, and finally, the R package Venn Diagram was used to take the intersection and obtain 7 hub genes. The time-dependent ROC curve and Kaplan-Meier survival curve were used to find the SERPINE1 gene, which plays a critical role in prognosis. Finally, the expression pattern, clinical characteristics, and regulatory mechanism of SERPINE1 were analyzed in STAD. We revealed that the expression of SERPINE1 was significantly increased in the samples from STAD compared with normal samples. Cox regression, time-dependent ROC, and Kaplan-Meier survival analyses demonstrated that SERPINE1 was significantly related to the adverse prognosis of STAD patients. The expression of SERPINE1 increased with the progression of T, N, and M classification of the tumor. In addition, the results of immune infiltration analysis indicated that the immune cells' expression were higher in high SERPINE1 expression group than that in low SERPINE1 expression group, including CD4

Indexed as

AdenocarcinomaStomach NeoplasmsBiomarkersCD8-Positive T-LymphocytesComputational BiologyData MiningHumansPlasminogen Activator Inhibitor 1PrognosisTumor MicroenvironmentBiomarkersPlasminogen Activator Inhibitor 1SERPINE1 protein, human

Identifiers

PMID36697459
PMCPMC9876925
OpenAlexW4318042026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.